http:\/\/orgspectroscopyint.blogspot.in\/2013\/11\/pregabalin-spectral-data.html<\/a><\/p>\n<\/div>\n In the\u00a0United States<\/a>, the\u00a0Food and Drug Administration<\/a>\u00a0(FDA) has approved pregabalin for\u00a0adjunctive therapy<\/a>\u00a0for adults with partial onset\u00a0seizures<\/a>, management of\u00a0postherpetic neuralgia<\/a>\u00a0andneuropathic pain<\/a>\u00a0associated with spinal cord injury and\u00a0diabetic peripheral neuropathy<\/a>, and the treatment of\u00a0fibromyalgia<\/a>.\u00a0Pregabalin has also been approved in the\u00a0European Union<\/a>\u00a0and\u00a0Russia<\/a>(but not in US) for treatment of\u00a0generalized anxiety disorder<\/a>.<\/p>\n <\/a><\/p>\n A package of 150 mg pregabalin (Finland)<\/p>\n<\/div>\n <\/p>\n READ AT ……………http:\/\/www.rsc.org\/chemistryworld\/News\/2008\/July\/09070801.asp<\/a><\/p>\n <\/p>\n <\/p>\n is also known as \u03b3-amino butyric acid or (S)-3-isobutyl GABA. (S)-Pregabalin, marketed under the name LYRICA\u00ae<\/sup>, has been found to activate GAD (L-glutamic acid decarboxylase). (S)-Pregabalin has a dose dependent protective effect on-seizure, and is a CNS-active compound. (S)-Pregabalin is useful in anticonvulsant therapy, due to its activation of GAD, promoting the production of GABA, one of the brain’s major inhibitory neurotransmitters, which is released at 30 percent of the brains synapses. (S)-Pregabalin has analgesic, anticonvulsant, and anxiolytic activity.<\/p>\n<\/div>\n<\/li>\n\n